Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Core Insights - Klotho Neurosciences, Inc. has announced the addition of Dr. Robert Langer to its Scientific Advisory Board, highlighting his belief in the company's mission and potential in developing therapies for neurodegenerative diseases [1][4] Company Overview - Klotho Neurosciences is focused on innovative therapies for neurodegenerative disorders such as ALS, Alzheimer's, and Parkinson's disease, leveraging research on the Klotho protein, which has shown neuroprotective potential in preclinical models [3][5] - The company holds patents for its secreted form of Klotho (s-KL) in the USA, Europe, Hong Kong, and China, indicating a strong intellectual property position [3] Dr. Robert Langer's Role - Dr. Langer is a prominent figure in biotechnology, known for his contributions to drug delivery systems and mRNA-based therapeutics, including the COVID-19 vaccine [2] - His involvement is expected to provide significant guidance on the scientific and clinical development of Klotho Neurosciences' product candidates, marking a milestone for the company [4] Strategic Direction - The company aims to position itself at the forefront of addressing the challenges of treating neurodegenerative diseases, with Dr. Langer's expertise seen as invaluable for advancing its pipeline [4]